FDA
-
-
-
-
-
-
-
Fennec Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
-
-
-
-
-
-
-
B.Riley Starts Fennec Pharmaceuticals Inc. (FENC) at Buy
-
-
-
-
-
-
-
Fennec Pharmaceuticals Announces Completion Of Full Debt Redemption
-
-
-
-
-
-
-
Fennec Pharmaceuticals prices $35 million share offering at $7.50
-
-
-
-
-
-
-
Fennec Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Fennec Pharmaceuticals Announces Pedmarqsi® Positive Recommendation by NICE for the Prevention of Cisplatin-Induced Hearing Loss in England and Wales
-
-
-
-
-
-
-
Fennec Pharmaceuticals Strengthens Executive Leadership Team with Three Key Appointments to Accelerate the Company’s Next Stage of Growth
-
322,914 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

